Screener
BioMarin Pharmaceuticals BMRN Income Taxes Payable
Income Taxes Payable at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccruedIncomeTaxesCurrent.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Accrued compensation expense | 220,506 | 219,422 |
| Accrued Interest | 47,129 | 907 |
| Foreign currency exchange forward contracts | 33,525 | 31,007 |
| Lease liability | 16,058 | 8,685 |
| Accrued royalties payable | 15,502 | 7,968 |
| Accrued income taxes | 9,137 | 3,667 |
| Other | 13,433 | 7,682 |
| Total accounts payable and accrued liabilities | $1,005,793 | $759,031 |
Item 1. Financial Statements
FAQ
- What is BioMarin Pharmaceuticals's income taxes payable?
- BioMarin Pharmaceuticals (BMRN) reported income taxes payable of $9.14M in Q2 2026.
- How has BioMarin Pharmaceuticals's income taxes payable changed year-over-year?
- BioMarin Pharmaceuticals's income taxes payable decreased by 31.8% year-over-year, from $13.4M to $9.14M.
- What is the long-term trend for BioMarin Pharmaceuticals's income taxes payable?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's income taxes payable has grown at a -17.6% compound annual growth rate (CAGR), from $9.66M to $3.67M.
- What does income taxes payable mean?
- Current income taxes owed to federal, state, and local tax authorities for the current and prior periods.
Ask your AI about BioMarin Pharmaceuticals's income taxes payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude